glp 1 drugs pros and cons Long-Term Effects Of GLP-1 Medications: What You Should Know The Surprising Truth About Nutrition

Initially, the neuroprotection of GLP-1RAs was tested in in vivo models of diabetes

Nonetheless, apprehensions persist regarding their elevated expense and the potential exacerbation of healthcare inequities [69, 70]

Using the same spot repeatedly can cause lipodystrophy, changes in the fatty tissue that affect absorption consistency

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

It can cause too low blood sugar in patients who take Wegovy with another glucose control medication, including insulin

This variability highlights why sourcing options, program eligibility, and clinician guidance are essential for practical affordability